Astera Labs (NASDAQ:ALAB) Trading Down 9.7% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALABGet Free Report)’s share price dropped 9.7% on Tuesday . The stock traded as low as $392.89 and last traded at $397.02. Approximately 6,455,858 shares traded hands during mid-day trading, an increase of 13% from the average daily volume of 5,711,881 shares. The stock had previously closed at $439.66.

Analysts Set New Price Targets

Several brokerages have recently issued reports on ALAB. Barclays increased their price objective on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Jefferies Financial Group reissued a “buy” rating and set a $270.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Susquehanna boosted their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Finally, Loop Capital started coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective for the company. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $254.75.

View Our Latest Report on ALAB

Astera Labs Price Performance

The company has a 50-day moving average price of $280.26 and a two-hundred day moving average price of $193.05. The company has a market cap of $72.15 billion, a PE ratio of 287.50, a P/E/G ratio of 5.26 and a beta of 3.95.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s revenue was up 93.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Activity

In other news, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the sale, the director directly owned 75,688 shares in the company, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total value of $1,277,046.75. Following the completion of the sale, the director owned 60,134 shares in the company, valued at $21,909,822.90. The trade was a 5.51% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,161,256 shares of company stock valued at $459,844,296 over the last quarter. 10.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ALAB. Eurizon Capital SGR S.p.A. acquired a new stake in shares of Astera Labs in the fourth quarter valued at $18,708,000. Nordea Investment Management AB acquired a new position in Astera Labs during the fourth quarter worth about $2,028,000. Geneva Partners LLC bought a new stake in Astera Labs in the third quarter worth about $1,876,000. Swedbank AB raised its position in Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after acquiring an additional 33,940 shares in the last quarter. Finally, Numerai GP LLC lifted its holdings in Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after acquiring an additional 7,992 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.